BLPH - Bellerophon Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Bellerophon Therapeutics's activity chart (see below) currently has 6 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from HC WAINWRIGHT on 06-Jun-2023. First documented stock forecast 19-Feb-2020.

Best performing analysts who are covering BLPH - Bellerophon Therapeutics:

Andrew Fein Yale Jen Kemp Dolliver

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Feb-2020

$2

$1.9 (1900.00%)

$30

3 years 4 months 18 days ago
(06-Jun-2023)

0/4 (0%)

$1.1 (122.22%)

Hold Since 06-Jun-2023

$35

3 years 4 months 18 days ago
(06-Jun-2023)

0/1 (0%)

$26.2 (297.73%)

Buy Since 23-Jun-2021

$19

$18.9 (18900.00%)

$26

4 years 6 months 20 days ago
(04-Apr-2022)

0/2 (0%)

$16.64 (705.08%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on BLPH (Bellerophon Therapeutics)?

Which analyst has the current lower performing score on BLPH (Bellerophon Therapeutics) with a proven track record?

KEMP DOLLIVER

Which analyst has the most public recommendations on BLPH (Bellerophon Therapeutics)?

has 0 price targets and 0 ratings on BLPH

Which analyst is the currently most bullish on BLPH (Bellerophon Therapeutics)?

Kemp Dolliver with the highest potential upside of $18.9

Which analyst is the currently most reserved on BLPH (Bellerophon Therapeutics)?

Yale Jen with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?